Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
Open Access
- 25 January 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21617
Abstract
Palliative radiotherapy (PRT) during the last month of life (PRT30) should be avoided because relevant clinical benefits are unlikely to occur. While traditional short-course fractionation regimens are suitable for most patients, a minority may derive gains from higher doses of PRT. Compared to older regimens such as 13 fractions of 3 Gy, more hypofractionated, non-ablative concepts with reduced overall treatment time are not well studied. Retrospective analysis (2017-2020) of 107 patients treated to metastatic lesions (one or two target volumes per patient) with traditional >2 weeks regimens or newer ≤2 weeks regimens, e.g. seven fractions of 5 Gy or five fractions of 6 Gy. Failure to complete radiotherapy was registered in 8% of patients (traditional fractionation) and 1%, respectively (p=0.12). Moderate rates of PRT30 were observed (11% and 6%, respectively, p=0.44). PRT30 was more likely in patients irradiated for brain or lymph node metastases. Utilization of newer ≤2 weeks regimens was highest in 2020, presumably as a result of the coronavirus disease 2019 (COVID-19) pandemic. The implementation of newer fractionation regimens for selected patients has resulted in acceptable rates of non-completion and PRT30. Optimal selection criteria remain to be determined. Established, guideline-endorsed short-course regimens such as five fractions of 4 Gy and 8-Gy single fractions continue to represent important PRT approaches.Keywords
This publication has 24 references indexed in Scilit:
- Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Palliative radiation therapy in the last 30 days of life: A systematic reviewRadiotherapy and Oncology, 2017
- Assessing the utilization of radiotherapy near end of life at a Finnish University Hospital: a retrospective cohort studyActa Oncologica, 2017
- Palliative radiotherapy during the last month of life: Predictability for referring physicians and radiation oncologistsOncology Letters, 2015
- Early palliative radiation therapy in patients with newly diagnosed cancer: Reasons, clinical practice, and survivalPractical Radiation Oncology, 2015
- 30 day mortality in adult palliative radiotherapy – A retrospective population based study of 14,972 treatment episodesRadiotherapy and Oncology, 2015
- Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.2014
- Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: The TEACHH modelCancer, 2013
- Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?Radiation Oncology, 2013
- A new isoeffect curve for change in dose per fractionRadiotherapy and Oncology, 1983